Low-dose oral minoxidil is a daily tablet, usually 0.25 to 5 mg, that treats pattern hair loss about as well as minoxidil applied to the scalp. Randomised trials and a meta-analysis found no clear difference in hair density between the two [3,4,5]. The main trade-off is more unwanted body and facial hair. In Switzerland it is prescribed off-label, so you need a doctor.
In short: Oral minoxidil is a reasonable option if twice-daily scalp application doesn't suit you. It is not stronger than topical minoxidil in head-to-head trials, but it is easier to use. Serious side effects are rare at low doses, but a doctor should check your heart and blood pressure first.
What is low-dose oral minoxidil?
Minoxidil was first developed as a blood pressure tablet, given at much higher doses than those now used for hair. Doctors noticed increased hair growth as a side effect, and a topical version was licensed for hair loss. In recent years, dermatologists have increasingly used very low oral doses, below those expected to lower blood pressure, for many types of hair loss [13].

A 2021 review in the Journal of the American Academy of Dermatology identified 17 studies with 634 patients. It concluded that oral minoxidil was an effective and well-tolerated alternative for healthy patients who struggle with topical products [1]. The European S3 guideline on androgenetic alopecia was published in 2018 [2], before most of the trials below.
For background on how minoxidil works and on the topical forms, see our main minoxidil guide.
Key studies at a glance
| Study | Design | n | Result |
|---|---|---|---|
| Penha et al., JAMA Dermatol 2024 [3] | Double-blind RCT, men, 5 mg oral vs 5% topical, 24 weeks | 90 (68 completed) | Oral not superior overall; better on the crown in photo assessment only |
| Asilian et al., J Cosmet Dermatol 2024 [4] | RCT, 1 mg oral vs 5% topical, 6 months | 65 | Both improved hair diameter; no significant difference between groups |
| Sobral et al., Int J Dermatol 2025 [5] | Meta-analysis of 4 RCTs | 279 | No difference in density or diameter; hypertrichosis about twice as common with oral |
| Gupta et al., JAMA Dermatol 2022 [6] | Network meta-analysis, 23 studies, men | – | 5 mg oral ranked highest for terminal hair count at 24 weeks |
| Vañó-Galván et al., JAAD 2021 [9] | Retrospective multicentre safety study | 1,404 | Hypertrichosis 15.1%; 1.7% stopped because of side effects |
| Chen et al., JAAD 2025 [11] | Meta-analysis, blood pressure | – | No significant change in blood pressure; heart rate up about 2.7 beats/min |
Oral vs topical minoxidil: does the tablet work better?
The best direct evidence comes from head-to-head randomised trials.
- In a double-blind trial in men with Norwood 3V to 5V hair loss, 5 mg oral minoxidil daily was not superior to 5% topical minoxidil twice daily after 24 weeks. On standardised photos, oral minoxidil did better on the crown (vertex) but not at the front [3].
- In a trial of 65 men and women, 1 mg oral and 5% topical minoxidil both improved hair diameter, with no significant difference between them [4].
- A 2025 meta-analysis that pooled four randomised trials (279 patients) found no difference in hair density or hair diameter [5].
Network meta-analyses, which compare treatments indirectly across many studies, give a slightly different picture. One found that 5 mg oral minoxidil produced the greatest increase in terminal hairs at 24 weeks, ahead of topical minoxidil and 1 mg finasteride [6]. A 2025 update concluded that dutasteride 0.5 mg was the most effective option overall [7]. A review ranked the oral options in this probable order: dutasteride 0.5 mg, finasteride 5 mg, minoxidil 5 mg, finasteride 1 mg, then minoxidil 0.25 mg [8].
The practical conclusion: oral minoxidil is roughly as effective as topical minoxidil, and higher doses may give more regrowth. Its main advantage is convenience, not strength. It also avoids the scalp irritation and greasy hair that make many people give up the topical form [1].
Doses used in studies
Studies have used doses between 0.25 mg and 5 mg per day [10]. Higher doses were linked to more side effects [10]. In practice:
| Group | Typical starting range in clinics | Notes |
|---|---|---|
| Women | about 0.5–1.25 mg daily | Lower doses because of facial hair risk |
| Men | about 1.25–2.5 mg daily, up to 5 mg | 5 mg was used in the largest male RCT [3] |
These ranges are a guide only. Your doctor should start low and adjust based on your response, blood pressure and side effects. Expert recommendations published in 2025 stress basic screening and patient education before starting [13].
Side effects: what large studies found
Unwanted hair growth
Hypertrichosis, meaning extra hair on the face, arms or body, is by far the most common side effect. It affected 15.1% of patients in a 1,404-patient study [9], 24% in a pooled analysis of 442 patients [10], and 49% of men taking 5 mg in the JAMA Dermatology trial [3]. Compared with topical minoxidil, the risk was about twice as high [5]. It is usually mild, but it is the main reason people stop: it caused about a third of discontinuations in a blood pressure meta-analysis [11].
Heart and blood pressure
In the 1,404-patient study, body-wide side effects were uncommon [9]:
- lightheadedness: 1.7%
- fluid retention: 1.3%
- faster heartbeat: 0.9%
- headache: 0.4%
No life-threatening events were seen, and only 1.7% stopped treatment because of side effects [9]. Ankle swelling was seen in 2% in the pooled analysis and was more common at higher doses [10].
A 2025 meta-analysis found no significant change in systolic or diastolic blood pressure at doses up to 5 mg, but heart rate rose by about 2.7 beats per minute on average [11]. Even in 254 patients with known high blood pressure, side effects were similar to the general population. Patients already taking three or more blood pressure drugs, or doxazosin, were more likely to stop [12].
Most of these safety data come from retrospective studies without control groups, so rare events could be missed [9,11].
Who should not take it
Talk to your doctor before starting if you have heart disease, low blood pressure, heart rhythm problems, kidney disease or take several blood pressure medicines. Oral minoxidil is not used during pregnancy or breastfeeding. Seek medical advice promptly if you notice chest pain, shortness of breath, marked swelling or a racing heart.
Oral minoxidil in Switzerland
- Prescription: oral minoxidil is not licensed for hair loss in Switzerland, so it is prescribed off-label. Many dermatologists have low-dose capsules made up by a pharmacy.
- Cost: pharmacy capsules typically cost around CHF 10–30 per month, plus doctor's visits. Basic health insurance generally does not cover hair loss treatment; see our guide on health insurance.
- Monitoring: expect a blood pressure and pulse check before starting and at follow-up.
Oral minoxidil does not block DHT, the hormone behind male pattern hair loss. Many men therefore combine it with finasteride. Women can read about their options in our guide to hair loss in women.
How strong is the evidence?
The evidence is moderate and growing, but has clear gaps:
- Few randomised trials. Only a handful of RCTs compare oral and topical minoxidil, and they are small (65–90 participants) and short (24–39 weeks) [3,4,5].
- Safety data are mostly retrospective. The large safety studies had no control group [9,12], and the blood pressure meta-analysis included uncontrolled studies with variable dosing [11].
- Indirect comparisons. Network meta-analyses rank treatments across different study populations, which is less reliable than head-to-head trials [6,7].
- Off-label use. No regulator has assessed oral minoxidil for hair loss, so there is no official dosing.
Overall, the data support oral minoxidil as a reasonable alternative to topical minoxidil, not as a clearly superior treatment. For a comparison with all other options, see our evidence overview on hair loss treatments.
When a hair transplant makes sense
Oral minoxidil can thicken thinning hair, but it cannot regrow hair on areas that have been bald for years. If your temples or crown are smooth after a year of consistent treatment, medication alone will not fill them. Check your stage on the Norwood scale and read our hair transplant guide. Many surgeons recommend continuing medication after a transplant to protect the native hair around the grafts.
Frequently asked questions
Is oral minoxidil better than topical minoxidil?
Not clearly. A meta-analysis of four randomised trials found no difference in hair density or hair diameter between oral and topical minoxidil. Oral minoxidil is easier to use, but causes unwanted body and facial hair about twice as often.
What dose of oral minoxidil is used for hair loss?
Studies used doses between 0.25 mg and 5 mg per day. Women are usually started at the lower end and men at a somewhat higher dose. The exact dose is set by your doctor after checking your blood pressure, pulse and medical history.
Is oral minoxidil safe?
In a study of 1,404 patients, serious side effects were not seen and only 1.7% stopped because of side effects. The most common problem was extra body or facial hair. Dizziness, fluid retention and a faster heartbeat are less common but need a doctor's attention.
Can I get oral minoxidil in Switzerland?
Yes, but only with a prescription. It is not licensed for hair loss, so doctors prescribe it off-label, often as low-dose capsules made up by a pharmacy. Health insurance usually does not pay for it.
How long does oral minoxidil take to work?
Most trials measured results after 24 weeks, about six months. Many people notice extra shedding in the first weeks, and the full effect is usually judged after 6 to 12 months of continuous use.
References
Numbers in the text refer to these sources. Links go to PubMed, the publisher (DOI) or the authority.
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol 2021.PubMedDOI
- Kanti V, Messenger A, Dobos G et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol 2018.PubMedDOI
- Penha MA, Miot HA, Kasprzak M et al. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol 2024.PubMedDOI
- Asilian A, Farmani A, Saber M. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. J Cosmet Dermatol 2024.PubMedDOI
- Sobral MVS, Moreira JLML, Rodrigues LK et al. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol 2025.PubMedDOI
- Gupta AK, Venkataraman M, Talukder M et al. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. JAMA Dermatol 2022.PubMedDOI
- Gupta AK, Bamimore MA, Williams G et al. Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical Evidence. J Cosmet Dermatol 2025.PubMedDOI
- Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. J Dermatolog Treat 2022.PubMedDOI
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol 2021.PubMedDOI
- Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R et al. Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data. Dermatol Ther 2020.PubMedDOI
- Chen M, Weichert M, Guo W et al. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis. J Am Acad Dermatol 2025.PubMedDOI
- Jimenez-Cauhe J, Pirmez R, Müller-Ramos P et al. Safety of Low-Dose Oral Minoxidil in Patients With Hypertension and Arrhythmia: A Multicenter Study of 264 Patients. Actas Dermosifiliogr 2024.PubMedDOI
- Olsen EA, Sinclair R, Hordinsky M et al. Summation and recommendations for the safe and effective use of topical and oral minoxidil. J Am Acad Dermatol 2025.PubMedDOI
This article is for general information and does not replace medical advice. Whether a treatment is right for you can only be determined by an examination with a specialist.